Eton Pharmaceuticals, Inc.: accounts_receivable
| Value | {"amount": 16400000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-03-31) |
| Status | current |
| Entity | Eton Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:30:35.976646+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2b7f9917-5ce6-4776-8e95-2cde164eaa31
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-25-016475Retrieved: 2026-08-19T17:30:35.976646+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001710340/accounts-receivable/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2b7f9917-5ce6-4776-8e95-2cde164eaa31
History
- no predecessors — first report